BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takeshima Y, Iwasaki Y, Nakano M, Narushima Y, Ota M, Nagafuchi Y, Sumitomo S, Okamura T, Elkon K, Ishigaki K, Suzuki A, Kochi Y, Yamamoto K, Fujio K. Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus. Ann Rheum Dis 2022:annrheumdis-2021-221464. [PMID: 35236659 DOI: 10.1136/annrheumdis-2021-221464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Guo Q, Dai D, Yu J, Wang L, Wu Z, Ding H, Shen N, Duan Y. Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121766] [Reference Citation Analysis]
2 Iwasaki Y, Takeshima Y, Nakano M, Okubo M, Ota M, Suzuki A, Kochi Y, Okamura T, Endo T, Miki I, Sakurada K, Yamamoto K, Fujio K. Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis. Rheumatology (Oxford) 2022:keac338. [PMID: 35689621 DOI: 10.1093/rheumatology/keac338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]